Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | 14,5x - 16,1x | 15,3x |
| Selected Fwd EBITDA Multiple | 10,2x - 11,2x | 10,7x |
| Fair Value | ﷼53,38 - ﷼58,99 | ﷼56,18 |
| Upside | -4,5% - 5,5% | 0,5% |
| Benchmarks | Ticker | Full Ticker |
| National Medical Care Company | 4005 | SASE:4005 |
| Naba Al Saha Medical Services Company | 9546 | SASE:9546 |
| Al Hammadi Holding Company | 4007 | SASE:4007 |
| Dr. Sulaiman Al Habib Medical Services Group Company | 4013 | SASE:4013 |
| Saudi Chemical Holding Company | 2230 | SASE:2230 |
| Qomel Company Limited | 9600 | SASE:9600 |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| 4005 | 9546 | 4007 | 4013 | 2230 | 9600 | ||
| SASE:4005 | SASE:9546 | SASE:4007 | SASE:4013 | SASE:2230 | SASE:9600 | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | 14.9% | NM- | 10.5% | 20.3% | 24.9% | NM- | |
| 3Y CAGR | 13.7% | 1.9% | 19.5% | 16.2% | 38.0% | 46.5% | |
| Latest Twelve Months | 13.0% | -33.3% | -5.9% | 18.4% | 19.1% | 27.2% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | 24.9% | 26.0% | 30.9% | 23.9% | 6.4% | 19.2% | |
| Prior Fiscal Year | 26.9% | 28.3% | 36.7% | 24.8% | 7.3% | 19.6% | |
| Latest Fiscal Year | 24.4% | 17.7% | 34.0% | 24.2% | 7.6% | 21.1% | |
| Latest Twelve Months | 25.1% | 17.7% | 33.2% | 24.1% | 7.6% | 21.1% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 5.18x | 3.65x | 4.84x | 7.98x | 1.21x | 3.14x | |
| EV / LTM EBITDA | 20.7x | 20.6x | 14.6x | 33.1x | 15.9x | 14.9x | |
| EV / LTM EBIT | 25.6x | 28.0x | 18.5x | 38.9x | 17.8x | 15.0x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | 14.6x | 20.6x | 33.1x | ||||
| Historical EV / LTM EBITDA | 14.9x | 14.9x | 14.9x | ||||
| Selected EV / LTM EBITDA | 14.5x | 15.3x | 16.1x | ||||
| (x) LTM EBITDA | 26 | 26 | 26 | ||||
| (=) Implied Enterprise Value | 382 | 402 | 422 | ||||
| (-) Non-shareholder Claims * | 1 | 1 | 1 | ||||
| (=) Equity Value | 383 | 403 | 423 | ||||
| (/) Shares Outstanding | 7.0 | 7.0 | 7.0 | ||||
| Implied Value Range | 54.65 | 57.52 | 60.39 | ||||
| FX Rate: SAR/SAR | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 54.65 | 57.52 | 60.39 | 55.90 | |||
| Upside / (Downside) | -2.2% | 2.9% | 8.0% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4005 | 9546 | 4007 | 4013 | 2230 | 9600 | |
| Enterprise Value | 7,154 | 707 | 5,706 | 94,020 | 7,717 | 390 | |
| (+) Cash & Short Term Investments | 677 | 43 | 291 | 2,548 | 198 | 47 | |
| (+) Investments & Other | 0 | 2 | 140 | 469 | 0 | 0 | |
| (-) Debt | (466) | (89) | (307) | (8,587) | (1,781) | (46) | |
| (-) Other Liabilities | 0 | 0 | 0 | (461) | (12) | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 7,365 | 662 | 5,830 | 87,990 | 6,122 | 391 | |
| (/) Shares Outstanding | 44.7 | 10.5 | 160.0 | 350.0 | 843.2 | 7.0 | |
| Implied Stock Price | 164.80 | 63.05 | 36.44 | 251.40 | 7.26 | 55.90 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 164.80 | 63.05 | 36.44 | 251.40 | 7.26 | 55.90 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |